23 related articles for article (PubMed ID: 38765410)
1. A clinical case of insulin autoimmune syndrome with monoclonal gammopathy of uncertain significance; complexity in management.
Clifford L; Joseph F; Joshi T
Oxf Med Case Reports; 2024 Jun; 2024(6):omae054. PubMed ID: 38860020
[TBL] [Abstract][Full Text] [Related]
2. Co-occurrence of High-Risk Myelodysplastic Syndrome With a Complex Karyotype/TP53 Mutation and IgG Lambda Monoclonal Gammopathy of Undetermined Significance.
Mir M; Aiman W; Baah E; Guron G; Shaaban H
Cureus; 2024 Apr; 16(4):e58451. PubMed ID: 38765410
[TBL] [Abstract][Full Text] [Related]
3. Defining new reference intervals for serum free light chains in individuals with chronic kidney disease: Results of the iStopMM study.
Long TE; Indridason OS; Palsson R; Rognvaldsson S; Love TJ; Thorsteinsdottir S; Sverrisdottir IS; Vidarsson B; Onundarson PT; Agnarsson BA; Sigurdardottir M; Thorsteinsdottir I; Olafsson I; Thordardottir AR; Eythorsson E; Jonsson A; Gislason G; Olafsson A; Steingrimsdottir H; Hultcrantz M; Durie BGM; Harding S; Landgren O; Kristinsson SY
Blood Cancer J; 2022 Sep; 12(9):133. PubMed ID: 36100605
[TBL] [Abstract][Full Text] [Related]
4. International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data.
Arber DA; Orazi A; Hasserjian RP; Borowitz MJ; Calvo KR; Kvasnicka HM; Wang SA; Bagg A; Barbui T; Branford S; Bueso-Ramos CE; Cortes JE; Dal Cin P; DiNardo CD; Dombret H; Duncavage EJ; Ebert BL; Estey EH; Facchetti F; Foucar K; Gangat N; Gianelli U; Godley LA; Gökbuget N; Gotlib J; Hellström-Lindberg E; Hobbs GS; Hoffman R; Jabbour EJ; Kiladjian JJ; Larson RA; Le Beau MM; Loh ML; Löwenberg B; Macintyre E; Malcovati L; Mullighan CG; Niemeyer C; Odenike OM; Ogawa S; Orfao A; Papaemmanuil E; Passamonti F; Porkka K; Pui CH; Radich JP; Reiter A; Rozman M; Rudelius M; Savona MR; Schiffer CA; Schmitt-Graeff A; Shimamura A; Sierra J; Stock WA; Stone RM; Tallman MS; Thiele J; Tien HF; Tzankov A; Vannucchi AM; Vyas P; Wei AH; Weinberg OK; Wierzbowska A; Cazzola M; Döhner H; Tefferi A
Blood; 2022 Sep; 140(11):1200-1228. PubMed ID: 35767897
[TBL] [Abstract][Full Text] [Related]
5. The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic/Dendritic Neoplasms.
Khoury JD; Solary E; Abla O; Akkari Y; Alaggio R; Apperley JF; Bejar R; Berti E; Busque L; Chan JKC; Chen W; Chen X; Chng WJ; Choi JK; Colmenero I; Coupland SE; Cross NCP; De Jong D; Elghetany MT; Takahashi E; Emile JF; Ferry J; Fogelstrand L; Fontenay M; Germing U; Gujral S; Haferlach T; Harrison C; Hodge JC; Hu S; Jansen JH; Kanagal-Shamanna R; Kantarjian HM; Kratz CP; Li XQ; Lim MS; Loeb K; Loghavi S; Marcogliese A; Meshinchi S; Michaels P; Naresh KN; Natkunam Y; Nejati R; Ott G; Padron E; Patel KP; Patkar N; Picarsic J; Platzbecker U; Roberts I; Schuh A; Sewell W; Siebert R; Tembhare P; Tyner J; Verstovsek S; Wang W; Wood B; Xiao W; Yeung C; Hochhaus A
Leukemia; 2022 Jul; 36(7):1703-1719. PubMed ID: 35732831
[TBL] [Abstract][Full Text] [Related]
6. Coexistence of plasma cell neoplasia and myelodysplastic syndrome with excess blasts: case reports and literature review.
Yan W; Qu XY; Li H; Li YC; Li Y; Yao K; Yang W; Wang HH
Ann Palliat Med; 2021 Dec; 10(12):12431-12440. PubMed ID: 35016480
[TBL] [Abstract][Full Text] [Related]
7. Regulating tumor suppressor genes: post-translational modifications.
Chen L; Liu S; Tao Y
Signal Transduct Target Ther; 2020 Jun; 5(1):90. PubMed ID: 32532965
[TBL] [Abstract][Full Text] [Related]
8. Genetics of progression from MDS to secondary leukemia.
Menssen AJ; Walter MJ
Blood; 2020 Jul; 136(1):50-60. PubMed ID: 32430504
[TBL] [Abstract][Full Text] [Related]
9. Complex karyotype in myelodysplastic syndromes: Diagnostic procedure and prognostic susceptibility.
Shahjahani M; Hadad EH; Azizidoost S; Nezhad KC; Shahrabi S
Oncol Rev; 2019 Jan; 13(1):389. PubMed ID: 30858933
[TBL] [Abstract][Full Text] [Related]
10.
Poulain S; Roumier C; Bertrand E; Renneville A; Caillault-Venet A; Doye E; Geffroy S; Sebda S; Nibourel O; Nudel M; Herbaux C; Renaud L; Tomowiak C; Guidez S; Tricot S; Roche-Lestienne C; Quesnel B; Preudhomme C; Leleu X
Clin Cancer Res; 2017 Oct; 23(20):6325-6335. PubMed ID: 28754818
[No Abstract] [Full Text] [Related]
11. Concomitant MDS with isolated 5q deletion and MGUS: case report and review of molecular aspects.
Nolte F; Mossner M; Jann JC; Nowak D; Boch T; Müller NZ; Hofmann WK; Metzgeroth G
Eur J Haematol; 2017 Mar; 98(3):302-310. PubMed ID: 27862375
[TBL] [Abstract][Full Text] [Related]
12. Clinical course of light-chain smouldering multiple myeloma (idiopathic Bence Jones proteinuria): a retrospective cohort study.
Kyle RA; Larson DR; Therneau TM; Dispenzieri A; Melton LJ; Benson JT; Kumar S; Rajkumar SV
Lancet Haematol; 2014 Oct; 1(1):e28-e36. PubMed ID: 25530988
[TBL] [Abstract][Full Text] [Related]
13. International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma.
Rajkumar SV; Dimopoulos MA; Palumbo A; Blade J; Merlini G; Mateos MV; Kumar S; Hillengass J; Kastritis E; Richardson P; Landgren O; Paiva B; Dispenzieri A; Weiss B; LeLeu X; Zweegman S; Lonial S; Rosinol L; Zamagni E; Jagannath S; Sezer O; Kristinsson SY; Caers J; Usmani SZ; Lahuerta JJ; Johnsen HE; Beksac M; Cavo M; Goldschmidt H; Terpos E; Kyle RA; Anderson KC; Durie BG; Miguel JF
Lancet Oncol; 2014 Nov; 15(12):e538-48. PubMed ID: 25439696
[TBL] [Abstract][Full Text] [Related]
14. Cytogenetic risk stratification of 417 patients with chronic myelomonocytic leukemia from a single institution.
Tang G; Zhang L; Fu B; Hu J; Lu X; Hu S; Patel A; Goswami M; Khoury JD; Garcia-Manero G; Medeiros LJ; Wang SA
Am J Hematol; 2014 Aug; 89(8):813-8. PubMed ID: 24782398
[TBL] [Abstract][Full Text] [Related]
15. Myelodysplastic syndromes.
Adès L; Itzykson R; Fenaux P
Lancet; 2014 Jun; 383(9936):2239-52. PubMed ID: 24656536
[TBL] [Abstract][Full Text] [Related]
16. Incidence of monoclonal gammopathy of undetermined significance and estimation of duration before first clinical recognition.
Therneau TM; Kyle RA; Melton LJ; Larson DR; Benson JT; Colby CL; Dispenzieri A; Kumar S; Katzmann JA; Cerhan JR; Rajkumar SV
Mayo Clin Proc; 2012 Nov; 87(11):1071-9. PubMed ID: 22883742
[TBL] [Abstract][Full Text] [Related]
17. Clinical impact of the clone size in MDS cases with monosomy 7 or 7q deletion, trisomy 8, 20q deletion and loss of Y chromosome.
Mallo M; Luño E; Sanzo C; Cervera J; Haase D; Schanz J; García-Manero G; del Cañizo C; Sanz GF; Solé F
Leuk Res; 2011 Jun; 35(6):834-6. PubMed ID: 21269692
[TBL] [Abstract][Full Text] [Related]
18. Monoclonal gammopathy of undetermined significance (MGUS) and smoldering (asymptomatic) multiple myeloma: IMWG consensus perspectives risk factors for progression and guidelines for monitoring and management.
Kyle RA; Durie BG; Rajkumar SV; Landgren O; Blade J; Merlini G; Kröger N; Einsele H; Vesole DH; Dimopoulos M; San Miguel J; Avet-Loiseau H; Hajek R; Chen WM; Anderson KC; Ludwig H; Sonneveld P; Pavlovsky S; Palumbo A; Richardson PG; Barlogie B; Greipp P; Vescio R; Turesson I; Westin J; Boccadoro M;
Leukemia; 2010 Jun; 24(6):1121-7. PubMed ID: 20410922
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]